The innate immune system in diabetic retinopathy

Area of Science:

• Ophthalmology
• Immunology
• Endocrinology

Background:

• Diabetes prevalence and complications, including diabetic retinopathy (DR), are rising globally.
• Diabetic retinopathy is the primary cause of vision loss in working-age adults in the US.
• Recent research indicates neuroretinal pathology precedes vascular changes in DR, implicating the innate immune system.

Purpose of the Study:

• To review the role of the innate immune system in diabetic retinopathy pathophysiology.
• To explore the involvement of immune cells, mediators, and the complement system in DR.
• To identify potential new therapeutic targets for DR based on immune system interactions.

Main Methods:

• Comprehensive literature review across various model systems.
• Analysis of molecular studies and clinical observations.
• Examination of anti-inflammatory therapeutic impacts in DR patients.

Main Results:

• The innate immune system, including immune-competent cells, mediators, and the complement system, plays a central role in DR.
• Immune dysregulation is a key factor in DR pathophysiology, disrupting homeostatic systems.
• The relative contribution of each immune pillar requires further investigation, especially in human tissues.

Conclusions:

• The intricate interactions within the immune system are critical to understanding diabetic retinopathy.
• Further research into the continuum of DR progression and immune involvement is necessary.
• Targeting the interconnected immune system pillars may offer novel strategies to reverse or halt DR progression.